FDA Inspection 771703 — Colgate Oral Pharmaceuticals, Inc.

Colgate Oral Pharmaceuticals, Inc. — FEI 1000117969

The FDA completed an inspection of Colgate Oral Pharmaceuticals, Inc. on Mar 9, 2012 in Dallas, TX. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Mar 9, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dallas, TX (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
121521 CFR 211.67(b)Written procedures not established/followed
202721 CFR 211.192Investigations of discrepancies, failures
241921 CFR 211.198(a)Complaint Handling Procedure
434521 CFR 211.160(b)(1)Samples (various types) representative, identified properly